| Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. | |
| | |
MedLine Citation:
|
PMID: 11555527 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Obstructive sleep apnea (OSA) is associated with cardiovascular morbidity and mortality. Plasma levels of homocysteine are also associated with cardiovascular morbidity and mortality. We therefore investigated homocysteine and conventional cardiovascular risk factors in OSA patients with and without cardiovascular morbidity in comparison with normal control subjects and ischemic heart disease (IHD) patients without OSA. SETTING: Technion Sleep Medicine Center, Haifa, Israel. METHODS AND PARTICIPANTS: Levels of homocysteine, cholesterol, low-density lipoprotein, high-density lipoprotein, triglycerides, creatinine, vitamins B(12) and B(6), and folic acid were determined in 345 participants after overnight fasting. These included OSA patients with IHD (n = 49), with hypertension (n = 61), or without any cardiovascular disease (n = 127). Two control groups were employed: IHD patients without or with low likelihood for sleep apnea (n = 35), and healthy control subjects (n = 73). RESULTS: After adjustment for age, body mass index, creatinine, and existence of diabetes mellitus, OSA patients with IHD had significantly higher homocysteine levels (14.6 +/- 6.77 micromol/L) than all other groups including the IHD-only patients. Hypertensive OSA patients had comparable homocysteine levels to IHD patients (11.80 +/- 5.28 micromol/L and 11.92 +/- 5.7 micromol/L, respectively), while patients with OSA only had comparable levels to normal control subjects (9.85 +/- 2.99 micromol/L and 9.78 +/- 3.49 micromol/L, respectively). No differences in conventional cardiovascular risk factors or in vitamin levels were found between groups. CONCLUSIONS: Patients with the combination of IHD and OSA have elevated homocysteine levels. We hypothesize that these results may be explained by endothelial dysfunction combined with excess free-radical formation in OSA patients. |
| | |
Authors:
|
L Lavie; A Perelman; P Lavie |
Related Documents
:
|
11229147 - Serum vitamin e in chronic myeloid leukaemia. 15122797 - Il-10 levels in dengue patients: some findings from the exceptional epidemiological con... 12161817 - Hypothalamic digoxin-mediated model for subacute sclerosing panencephalitis. 16440877 - Mandibuloacral dysplasia: a report of two egyptian cases. 18203737 - Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker p... 19149227 - The utilization of antibiotics in the management of acute pancreatitis--experience from... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Chest Volume: 120 ISSN: 0012-3692 ISO Abbreviation: Chest Publication Date: 2001 Sep |
Date Detail:
|
Created Date: 2001-09-13 Completed Date: 2001-10-11 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0231335 Medline TA: Chest Country: United States |
Other Details:
|
Languages: eng Pagination: 900-8 Citation Subset: AIM; IM |
Affiliation:
|
Unit of Anatomy and Cell Biology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. lenal@tx.technion.ac.il |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Endothelium, Vascular / physiopathology Folic Acid / blood Homocysteine / blood* Humans Male Middle Aged Myocardial Ischemia / blood*, physiopathology Pyridoxine / blood Risk Factors Sleep Apnea Syndromes / blood*, physiopathology |
| Chemical | |
Reg. No./Substance:
|
454-28-4/Homocysteine; 59-30-3/Folic Acid; 65-23-6/Pyridoxine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nocturnal hypoxemia is common in primary pulmonary hypertension.
Next Document: Impact of different criteria for defining hypopneas in the apnea-hypopnea index.